NexturnBioscience Co. Ltd (089140) — Capital Reinvestment Ratio
NexturnBioscience Co. Ltd (089140) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.51 Billion) in capital expenditures (₩286.65 Million). Check 089140 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NexturnBioscience Co. Ltd Capital Reinvestment Ratio (2007–2021)
This chart tracks NexturnBioscience Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of NexturnBioscience Co. Ltd.
Annual Capital Reinvestment Ratio for NexturnBioscience Co. Ltd (2007–2021)
Year-by-year Capital Reinvestment Ratio for NexturnBioscience Co. Ltd from 2007 to 2021. See 089140 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.13x | ₩3.66 Billion | ₩467.60 Million | ▼ -97.5% |
| 2020 | 5.15x | ₩235.94 Million | ₩1.21 Billion | ▼ -23.4% |
| 2019 | 6.72x | ₩2.74 Billion | ₩18.38 Billion | ▲ +32348.4% |
| 2018 | 0.02x | ₩9.63 Billion | ₩199.42 Million | ▼ -87.9% |
| 2017 | 0.17x | ₩5.08 Billion | ₩870.45 Million | ▲ +242.6% |
| 2016 | 0.05x | ₩17.88 Billion | ₩893.46 Million | ▼ -89.4% |
| 2015 | 0.47x | ₩1.92 Billion | ₩906.54 Million | ▲ +34050.2% |
| 2014 | 0.00x | ₩6.48 Billion | ₩8.97 Million | ▼ -100.0% |
| 2010 | 5.15x | ₩235.94 Million | ₩1.21 Billion | ▲ +7445.3% |
| 2009 | 0.07x | ₩998.03 Million | ₩68.11 Million | ▼ -67.3% |
| 2008 | 0.21x | ₩945.34 Million | ₩197.16 Million | ▼ -88.1% |
| 2007 | 1.75x | ₩2.26 Billion | ₩3.97 Billion | — |